China Shineway Pharmaceutical Releases 2025 Annual and ESG Reports; AGM Materials Now Online

Bulletin Express

Apr 23

China Shineway Pharmaceutical Group Limited announced that the English and Chinese versions of its 2025 Annual Report, the circular and notice of the upcoming Annual General Meeting (AGM), and the associated proxy form have been published. All documents are available on both the company’s website (www.shineway.com.hk) and HKEXnews (www.hkexnews.hk).

The notification, dated 24 April 2026, also confirms the simultaneous release of the group’s 2025 Environmental, Social and Governance (ESG) Report, likewise accessible through the same online platforms under the “Investor Relations” section.

Non-registered shareholders who prefer electronic delivery of future corporate communications are instructed to provide a functional email address via their designated intermediaries—banks, brokers, custodians, nominees or HKSCC Nominees Limited. Until an email address is recorded, shareholders will not receive digital alerts and must independently check the two websites for updates.

Those wishing to obtain printed copies of the current or future documents should submit a written request at least 10 days in advance to the company’s Hong Kong share registrar, Computershare Hong Kong Investor Services Limited (17M Floor, Hopewell Centre, 183 Queen’s Road East, Wan Chai, Hong Kong), email ChinaShineway.ecom@computershare.com.hk, or call +852 2862 8555 during business hours.

Company Secretary Lee Bun Ching Terence signed the notice on behalf of China Shineway Pharmaceutical Group Limited.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1172463170"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1172463170\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1172463170?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-23 18:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1172463170","market":"hk","top_or_hot":-1,"title":"China Shineway Pharmaceutical Releases 2025 Annual and ESG Reports; AGM Materials Now Online","media":"Bulletin Express","content":"<p>China Shineway Pharmaceutical Group Limited announced that the English and Chinese versions of its 2025 Annual Report, the circular and notice of the upcoming Annual General Meeting (AGM), and the associated proxy form have been published. All documents are available on both the company’s website (www.shineway.com.hk) and HKEXnews (www.hkexnews.hk).</p>\n<p>The notification, dated 24 April 2026, also confirms the simultaneous release of the group’s 2025 Environmental, Social and Governance (ESG) Report, likewise accessible through the same online platforms under the “Investor Relations” section.</p>\n<p>Non-registered shareholders who prefer electronic delivery of future corporate communications are instructed to provide a functional email address via their designated intermediaries—banks, brokers, custodians, nominees or HKSCC Nominees Limited. Until an email address is recorded, shareholders will not receive digital alerts and must independently check the two websites for updates.</p>\n<p>Those wishing to obtain printed copies of the current or future documents should submit a written request at least 10 days in advance to the company’s Hong Kong share registrar, Computershare Hong Kong Investor Services Limited (17M Floor, Hopewell Centre, 183 Queen’s Road East, Wan Chai, Hong Kong), email ChinaShineway.ecom@computershare.com.hk, or call +852 2862 8555 during business hours.</p>\n<p>Company Secretary Lee Bun Ching Terence signed the notice on behalf of China Shineway Pharmaceutical Group Limited.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China Shineway Pharmaceutical Releases 2025 Annual and ESG Reports; AGM Materials Now Online</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina Shineway Pharmaceutical Releases 2025 Annual and ESG Reports; AGM Materials Now Online\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-23 18:25</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>China Shineway Pharmaceutical Group Limited announced that the English and Chinese versions of its 2025 Annual Report, the circular and notice of the upcoming Annual General Meeting (AGM), and the associated proxy form have been published. All documents are available on both the company’s website (www.shineway.com.hk) and HKEXnews (www.hkexnews.hk).</p>\n<p>The notification, dated 24 April 2026, also confirms the simultaneous release of the group’s 2025 Environmental, Social and Governance (ESG) Report, likewise accessible through the same online platforms under the “Investor Relations” section.</p>\n<p>Non-registered shareholders who prefer electronic delivery of future corporate communications are instructed to provide a functional email address via their designated intermediaries—banks, brokers, custodians, nominees or HKSCC Nominees Limited. Until an email address is recorded, shareholders will not receive digital alerts and must independently check the two websites for updates.</p>\n<p>Those wishing to obtain printed copies of the current or future documents should submit a written request at least 10 days in advance to the company’s Hong Kong share registrar, Computershare Hong Kong Investor Services Limited (17M Floor, Hopewell Centre, 183 Queen’s Road East, Wan Chai, Hong Kong), email ChinaShineway.ecom@computershare.com.hk, or call +852 2862 8555 during business hours.</p>\n<p>Company Secretary Lee Bun Ching Terence signed the notice on behalf of China Shineway Pharmaceutical Group Limited.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02877","symbol_name":"神威药业","start_time":0,"source_url":"","article_id":"1172463170","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1172463170","pubTimestamp":1776939943,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"China Shineway Pharmaceutical Group Limited announced that the English and Chinese versions of its 2025 Annual Report, the circular and notice of the upcoming Annual General Meeting (AGM), and the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02877":"神威药业"},"translate_title":"中国神威药业发布2025年度及ESG报告；年度股东大会材料现已上线","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02877":1},"content_text":"China Shineway Pharmaceutical Group Limited announced that the English and Chinese versions of its 2025 Annual Report, the circular and notice of the upcoming Annual General Meeting (AGM), and the associated proxy form have been published. All documents are available on both the company’s website (www.shineway.com.hk) and HKEXnews (www.hkexnews.hk).\nThe notification, dated 24 April 2026, also confirms the simultaneous release of the group’s 2025 Environmental, Social and Governance (ESG) Report, likewise accessible through the same online platforms under the “Investor Relations” section.\nNon-registered shareholders who prefer electronic delivery of future corporate communications are instructed to provide a functional email address via their designated intermediaries—banks, brokers, custodians, nominees or HKSCC Nominees Limited. Until an email address is recorded, shareholders will not receive digital alerts and must independently check the two websites for updates.\nThose wishing to obtain printed copies of the current or future documents should submit a written request at least 10 days in advance to the company’s Hong Kong share registrar, Computershare Hong Kong Investor Services Limited (17M Floor, Hopewell Centre, 183 Queen’s Road East, Wan Chai, Hong Kong), email ChinaShineway.ecom@computershare.com.hk, or call +852 2862 8555 during business hours.\nCompany Secretary Lee Bun Ching Terence signed the notice on behalf of China Shineway Pharmaceutical Group Limited.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}